SCHEMBL7119672

SCHEMBL7119672

O=C(Nc1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
LMNA P02545 6/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
KMT2A Q03164 8/20 0.64
MAPT P10636 7/20 0.64
MEN1 O00255 6/20 0.64
MAPK1 P28482 4/20 0.64
CYP3A4 P08684 2/20 0.64
PPARG P37231 2/20 0.64
TP53 P04637 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C9 P11712 1/20 0.64
PKM P14618 1/20 0.64
TSHR P16473 1/20 0.64
NFKB1 P19838 1/20 0.64
CYP2C19 P33261 1/20 0.64
THPO P40225 1/20 0.64
MTOR P42345 1/20 0.64
RORC P51449 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122827 0.96 ALDH1A1 (0.72) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7121663 0.91 SMN1; SMN2 (0.67) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL27571256 0.89 ALDH1A1 (0.65) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7118778 0.86 MAPT (0.66) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7125457 0.86 POLB (0.68) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7119693 0.85 MAPT (0.63) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7130365 0.84 KMT2A (0.71) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL5502244 0.84 KMT2A (0.60) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7128371 0.84 KMT2A (0.62) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL7128789 0.84 MAPT (0.81) LMNASMN1; SMN2KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD ALDH1A1 583/4885LMNA 3310/4885SMN1; SMN2 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.